Deltec Asset Management’s Esperion Therapeutics ESPR Stock Holding History

Deltec Asset Management’s Portfolio ESPR Stock Details ESPR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-252,050	Closed	-$796K	–	261
2026 Q2	$796K	Buy	+252,050	New	+$705K	0.12%	121

Deltec Asset Management's ESPR Position: Q3 2026 in Review

Deltec Asset Management sold out of Esperion Therapeutics (ESPR) in Q3 2026, closing a stake of 252,050 shares — an estimated $796K sold.

Deltec Asset Management first reported a position in ESPR in Q2 2026 and held it in 1 quarter. The position peaked at $796K in Q2 2026. 1 fund tracked by Wall St. Rank holds ESPR as of Q3 2026.

Deltec Asset Management reported no remaining Esperion Therapeutics position as of Q3 2026 after selling out during the quarter.
Deltec Asset Management sold 252,050 Esperion Therapeutics shares in Q3 2026, an estimated $796K.
Deltec Asset Management first reported a position in Esperion Therapeutics in Q2 2026 and held it in 1 quarter.
Deltec Asset Management's Esperion Therapeutics position peaked at $796K in Q2 2026.
1 fund tracked by Wall St. Rank held Esperion Therapeutics as of Q3 2026.

Based on Deltec Asset Management's 13F filing for Q3 2026, filed 26 Oct 2026.